SIRT6 Activator Research
SIRT6 is one of seven mammalian sirtuins — NAD+-dependent enzymes that regulate gene expression, DNA repair, and cellular metabolism. It sits primarily in the nucleus, where it deacetylates histones, mono-ADP-ribosylates DNA repair proteins, and silences retrotransposable elements. SIRT6 activity declines with age; mice with reduced SIRT6 age prematurely, and mice with extra SIRT6 live longer. This hub tracks the emerging evidence on compounds that stimulate SIRT6 enzymatic activity. The current dominant class is fucoidans — sulphated polysaccharides from brown seaweed — with additional candidates emerging from plant polyphenol and small-molecule chemistry. Every paper here has been indexed to its source PubMed record and is grouped by what the evidence actually tells us: DNA repair, cellular senescence, healthspan, and safety.
Evidence at a glance
Cardiovascular
Cellular Senescence
DNA repair
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Landmark preclinical genetic knockout study establishing the mammalian SIRT6 phenotype in cells and mice; foundational loss-of-function evidence with no human data.
Tier 3SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Mechanistic cell-based study across human fibroblasts, osteosarcoma cells, and mouse embryonic fibroblasts with in vitro biochemistry. Translational relevance to Werner syndrome premature ageing, but no direct human clinical evidence.
Tier 3SIRT6 is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived Species
Cross-species comparative biology with cell-based DNA repair assays, biochemical characterisation of SIRT6 mutants, and Drosophila lifespan validation. Preclinical scope only, but strong causal inference through amino acid swap experiments.
Tier 3SIRT6 is a DNA double-strand break sensor
Preclinical mechanistic study using human U2OS and HeLa cell lines with purified recombinant SIRT6 protein. Combines live imaging of GFP-tagged proteins after UV laser-induced damage, in vitro DNA-binding assays, LacO tethering assays, and site-directed mutagenesis of the predicted DNA-binding tunnel. Foundational mechanism paper — first to demonstrate direct DNA-binding by any sirtuin — but entirely cell-culture and biochemical, no human or animal data.
Hepatic
Longevity
Metabolic
Neurological
Neuroprotective functions for the histone deacetylase SIRT6
Mechanistic preclinical study combining brain-specific conditional knockout mouse, cellular CRISPR and shRNA models, and human Alzheimer's disease tissue analysis; published in a peer-reviewed journal.
Tier 3SIRT6 is a key regulator of mitochondrial function in the brain
Preclinical multi-omics study in brain-specific SIRT6-knockout mice with functional validation in human neuroblastoma cells and cross-reference against published human brain aging and neurodegenerative disease datasets. Strong mechanistic depth, but the human comparison is transcriptomic overlap rather than clinical intervention.
Ophthalmic
Sirtuins
Restoration of energy homeostasis by SIRT6 extends healthy lifespan
Preclinical whole-organism study in two mouse cohorts (male and female inbred C57BL/6JOlaHsd) with lifespan endpoint, in vivo multi-omics, and 13C isotope tracing. Robust mechanism, but no human data.
Tier 4SIRT6 promotes DNA repair under stress by activating PARP1
Mechanistic in vitro and cell-culture study establishing SIRT6–PARP1 interaction and identifying PARP1 K521 as the mono-ADP-ribosylation site. Foundational mechanism, no whole-organism efficacy data.
Tier 3Sirtuin 6 activation rescues the age-related decline in DNA damage repair in primary human chondrocytes
Ex vivo human primary chondrocyte study across three age groups with pharmacological SIRT6 modulation, complemented by aged murine chondrocyte data. Human tissue is authentic but not a randomised human trial; results are chondrocyte-level, not clinical.
Tier 3SIRT6 activator fucoidan extends healthspan and lifespan in aged wild-type mice
Preclinical whole-organism study with lifespan and frailty endpoints in inbred male and female C57BL/6JN mice, supported by in vitro biochemistry and multi-omics tissue analysis. Not peer-reviewed at time of population.
Tier 3SIRT6, a protein with many faces
Comprehensive narrative review of SIRT6 in vitro biochemistry, mammalian cell biology, and murine genetic models. No systematic-review methodology and no human clinical trial data available at time of writing, but the field's foundational synthesis for the SIRT6 mechanism-to-lifespan story.
Tier 3A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A
Human genetic association study combined with extensive in vitro biochemistry and human cell-line characterisation of the centenarian SIRT6 variant; the genetic enrichment was not statistically significant due to cohort size, and there is no human clinical or lifespan outcome data.
Tier 3Sirtuin 6: linking longevity with genome and epigenome stability
Comprehensive narrative review synthesising mouse knockout, mouse overexpression, primate, cell-biological, and biochemical evidence on SIRT6, with limited human observational data (polymorphism association studies) and no human clinical trial data.
Tier 2SIRT6 Widely Regulates Aging, Immunity, and Cancer
Comprehensive narrative review synthesising in vitro, animal, and clinical evidence on SIRT6's three enzymatic activities and their roles across ageing, immunity, and cancer. Not primary data, but the reference synthesis for SIRT6's context-dependent (dual) role in cancer across 12+ tumour types.
Tier 3Association of SIRT6 Gene Polymorphisms with Human Longevity
Human case-control genetic association study, single site, moderate sample size (503 total). Reported longevity association at the allele-frequency level but the adjusted multinomial logistic regression found no independent effect of the SIRT6 rs350846 genotype after controlling for BMI, blood pressure, and HDL cholesterol. Best treated as hypothesis-generating for the SIRT6-human-longevity link, not confirmatory.
Tier 2SIRT6 in DNA Repair, Metabolism, and Ageing
Comprehensive narrative review synthesising the SIRT6 literature two years after the founding Mostoslavsky 2006 knockout paper. Not primary data. The framing citation for how the field integrated DNA repair, metabolism, and ageing under a single SIRT6 umbrella — cited repeatedly by every subsequent SIRT6 review through 2025.